IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Current Enzyme Inhibition

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.71

h-Index

2022-2023

 18

Rank

2022-2023

 20529

SJR

2022-2023

 0.174

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Current Enzyme Inhibition
Abbreviation Curr. Enzyme Inhib.
Publication Type Journal
Subject Area, Categories, Scope Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)
h-index 18
Overall Rank/Ranking 20529
SCImago Journal Rank (SJR) 0.174
Impact Score 0.71
Publisher Bentham Science Publishers B.V.
Country United Arab Emirates
ISSN 15734080
Best Quartile Q4
Coverage History 2006-2022




About Current Enzyme Inhibition


Current Enzyme Inhibition is a journal covering the technologies/fields/categories related to Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Current Enzyme Inhibition is 20529. According to SCImago Journal Rank (SJR), this journal is ranked 0.174. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 18. The best quartile for this journal is Q4.

The ISSN of Current Enzyme Inhibition journal is 15734080. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Enzyme Inhibition is cited by a total of 46 articles during the last 3 years (Preceding 2022).


Current Enzyme Inhibition Impact IF 2022-2023


The Impact IF 2022 of Current Enzyme Inhibition is 0.71, which is computed in 2023 as per its definition. Current Enzyme Inhibition IF is increased by a factor of 0.01 and approximate percentage change is 1.43% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Enzyme Inhibition Impact IF 2023 Prediction


Impact IF 2022 of Current Enzyme Inhibition is 0.71. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Current Enzyme Inhibition. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.71
2021 0.70
2020 0.40
2019 0.68
2018 0.34
2017 0.65
2016 0.33
2015 0.24
2014 0.43

Current Enzyme Inhibition h-index


  Table Setting

Current Enzyme Inhibition has an h-index of 18. It means 18 articles of this journal have more than 18 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Enzyme Inhibition ISSN


The ISSN of Current Enzyme Inhibition is 15734080. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Enzyme Inhibition Rank and SCImago Journal Rank (SJR)


The overall rank of Current Enzyme Inhibition is 20529. According to SCImago Journal Rank (SJR), this journal is ranked 0.174. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Current Enzyme Inhibition by Year


Year SJR
2023/2024 Coming Soon
2022 0.174
2021 0.157
2020 0.157
2019 0.204
2018 0.153
2017 0.197
2016 0.170
2015 0.143
2014 0.212

Ranking of Current Enzyme Inhibition by Year


Year Ranking
2023/2024 Coming Soon
2022 20529
2021 20733
2020 22475
2019 18252
2018 21070
2017 17609
2016 19632
2015 21679
2014 16519

Current Enzyme Inhibition Publisher


Table Setting

Current Enzyme Inhibition is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Enzyme Inhibition is Curr. Enzyme Inhib.. This abbreviation ('Curr. Enzyme Inhib.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Enzyme Inhibition


If your research field is/are related to Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Current Enzyme Inhibition?

Current Enzyme Inhibition latest impact IF is 0.71. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.71 (2022) and 0.24 (2015), respectively, in the last 9 years. Moreover, its average IS is 0.5 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Current Enzyme Inhibition?

The Current Enzyme Inhibition has an SJR (SCImago Journal Rank) of 0.174, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.212 in 2014 and the lowest being 0.143 in 2015. Furthermore, the average SJR of the Current Enzyme Inhibition over the previous 9-year period stands at 0.5.


What's the latest h-index of the Current Enzyme Inhibition?

The latest h-index of the Current Enzyme Inhibition is 18.


Who's the publisher of the Current Enzyme Inhibition?

The Current Enzyme Inhibition is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.


What's the current ranking of the Current Enzyme Inhibition?

The Current Enzyme Inhibition is currently ranked 20529 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 16519 in 2014 and its lowest position of 22475 in 2020.


What's the abbreviation or short name for the Current Enzyme Inhibition?

The standard ISO4 abbreviation for the Current Enzyme Inhibition is Curr. Enzyme Inhib..


Is the "Current Enzyme Inhibition" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Current Enzyme Inhibition is classified as a journal that the Bentham Science Publishers B.V. publishes.


What's the scope or major areas of the Current Enzyme Inhibition?

The Current Enzyme Inhibition encompasses the following areas:

  • Biochemistry
  • Drug Discovery
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Current Enzyme Inhibition?

The Current Enzyme Inhibition is assigned the following International Standard Serial Numbers (ISSN): 15734080.


What's the best quartile of the Current Enzyme Inhibition?

The best quartile for the Current Enzyme Inhibition is Q4 (2022).


What's the coverage history of the Current Enzyme Inhibition?

The Current Enzyme Inhibition coverage history can be summarized as follows: 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Zeitschrift fur Germanistische Linguistik journal 22945 De Gruyter Mouton 15 0.19
Socialism and Democracy journal 26162 Taylor and Francis Ltd. 17 0.09
Libyan Studies journal 16122 Cambridge University Press 8 0.45
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00
Indian Phytopathology journal 14222 Springer Nature 11 1.33
Built Environment journal 12797 Alexandrine Press 43 1.15
European Journal of Wildlife Research journal 8709 Springer Verlag 56 1.99
HOMO- Journal of Comparative Human Biology journal 19810 Elsevier BV 35 0.56
Brazilian Symposium of Computer Graphic and Image Processing conference and proceedings 16004 32 0.00

Check complete list




Year wise Impact Score (IS) of Current Enzyme Inhibition

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.71
2021 0.70
2020 0.40
2019 0.68
2018 0.34
2017 0.65
2016 0.33
2015 0.24
2014 0.43



Top Journals/Conferences in Biochemistry

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

Annual Review of Biophysics
Annual Reviews Inc. | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All